The treatment of melanoma with an emphasis on immunotherapeutic strategies

This publication has 96 references indexed in Scilit:

• Sentinel lymphonodectomy does not increase the risk of loco-regional cutaneous metastases of malignant melanomas
  European Journal Of Cancer, 2005
• Selective lymphadenectomy in sentinel node-positive patients may increase the risk of local/in-transit recurrence in malignant melanoma
  European Journal of Surgical Oncology, 2004
• Phase I Trial of Large Multivalent Immunogen Derived from Melanoma Lysates in Patients with Disseminated Melanoma
  Clinical Cancer Research, 2004
• Results of a phase I clinical study using autologous tumour lysate-pulsed monocyte-derived mature dendritic cell vaccinations for stage IV malignant melanoma patients combined with low dose interleukin-2
  Melanoma Research, 2003
• The incidence of malignant melanoma in the United States: Issues as we approach the 21st century
  Journal of the American Academy of Dermatology, 1996
• Gastrointestinal metastases from malignant melanoma
  Surgical Oncology, 1995
• Treatment of Patients With Metastatic Melanoma With Autologous Tumor-Infiltrating Lymphocytes and Interleukin 2
  JNCI Journal of the National Cancer Institute, 1994
• Use of Tumor-Infiltrating Lymphocytes and Interleukin-2 in the Immunotherapy of Patients with Metastatic Melanoma
  New England Journal of Medicine, 1988
• A New Approach to the Adoptive Immunotherapy of Cancer with Tumor-Infiltrating Lymphocytes
  Science, 1986
• Observations on the Systemic Administration of Autologous Lymphokine-Activated Killer Cells and Recombinant Interleukin-2 to Patients with Metastatic Cancer
  New England Journal of Medicine, 1985